KAHR Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 21
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 10

KAHR General Information

Description

Operator of immuno-recruitment cancer drugs company designed to activate immune responses by converting cancer camouflage into beacons for the immune system to attack. The company's platform uses the multifunctional immuno-recruitment protein (MIRP) technology to overcome the ability of cancers to evade recognition and elimination by the immune system, enabling doctors to help in reducing patient's cancer cells.

Contact Information

Website
www.kahrbio.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 1 Kiryat Hadassah JBP Building
  • POB 9779
  • Jerusalem 9109701
  • Israel
+972 000-000-0000

KAHR Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KAHR Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KAHR‘s full profile, request access.

Request a free trial

KAHR Executive Team (10)

Name Title Board Seat Contact Info
Yaron Pereg Ph.D Chief Executive Officer
Bryan Jennings Chief Financial Officer
Ayelet Chajut Ph.D Chief Technology Officer
Michal Elhalel MD Chief Scientific Officer
Iris Pecker Vice President, CMC
You’re viewing 5 of 10 executive team members. Get the full list »

KAHR Board Members (11)

Name Representing Role Since
0000 0000000000000 Self Board Member 000 0000
0000000 00000000 Sanofi Genzyme Board Member 000 0000
0000-00000 0000 00.0 Self Board Member 000 0000
000 0000 000 Self Board Observer 000 0000
00000000 00000000 00.0 Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

KAHR Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KAHR Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KAHR‘s full profile, request access.

Request a free trial